~~<i id='DA972FAA70'><strike id='DA972FAA70'><tt id='DA972FAA70'><pre id='DA972FAA70'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：Wikipedia 2025-09-14 06:53:24 - browse：5

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Hospital price transparency does save money, advocate argues

focus

hotspot

entertainment

Wikipedia

leisure time

STATWhenMichaelJ.FoxwasdiagnosedwithParkinson’sdiseaseatage29,hisclearestsymptomwasasmallone—hispink

WSS

The explosion of genetic testing requires a new approach

Couple fighting to bring baby home from Mexico are finally reunited

UnitedHealth’s board chair also owns a personal investment firm

CEOs share strategies for surviving biotech slump

States increasingly look to regulate hospital facility fees

HHS leader on health, climate change and biopharma emissions

hotspot

fashion

focus

ChatGPT in medicine: STAT answers readers' burning questions

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How dance can help health care workers heal from trauma

Heart attack and stroke risk calculators need revising

Will Ozempic

Malaria cases in Florida and Texas: Here’s what you need to know

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

As demand for Covid shots wanes, Moderna seeks its next success

Stanford updates investigation of president’s past research

focus

STAT Summit: How a Chicago ER doctor tackles gun violence

Pharmacists can make shortage drugs, but at what cost?

Seattle police shoot person suspected in downtown stabbing

Ebola public health emergency is over, WHO declares

Plane’s emergency slide plummets from sky, hits Chicago home

Eli Lilly expects to double planned employment in Boston center

hotspot

entertainment

Wikipedia

leisure time